United States: Monthly Stock Market Performance Insight - March 2025

Monthly Gainers
1,511
Monthly Losers
4,452
Average Return
-4.38%
Total Stocks
6,167
View Detailed Market Cap Breakdown
Market Cap Monthly Gainers Monthly Losers Average Return Total Stocks
Mega Cap 14 33 -4.45% 47
Large Cap 224 499 -3.35% 723
Mid Cap 235 746 -5.41% 986
Small Cap 115 389 -6.61% 508

Monthly Streak Leaders for March 2025

Stock Streak Streak Return
3 months โ†‘ 30.81%

Philip Morris shows promise with a 3-month winning streak (121.34 โ†’ 158.73), delivering 30.8% gains. The financials tell a compelling story: 9.3B revenue generating 2.8B net profit (30.5% margin) demonstrates exceptional profit margins as of Qtr ending Mar 2025.

3 months โ†‘ 23.87%

AT&T starts to shine with a 3-month winning streak (22.83 โ†’ 28.28), delivering 23.9% gains. The financials tell a compelling story: 30.6B revenue generating 4.7B net profit (15.3% margin) demonstrates exceptional profit margins as of Qtr ending Mar 2025.

4 months โ†“ -10.95%

Microsoft pulls back after a 4-month decline (421.57 โ†’ 375.39), down 11.0%. However, fundamentals remain robust: 69.6B revenue generating 24.1B profit (34.6% margin) as of Qtr ending Dec 2024 suggests this could be a temporary setback. Value hunters take note.

3 months โ†“ -29.10%

Broadcom takes a breather following a 3-month decline (236.16 โ†’ 167.43), down 29.1%. However, fundamentals remain robust: 15.0B revenue generating 5.0B profit (33.1% margin) as of Qtr ending Apr 2025 suggests this could be a temporary setback. Value hunters take note.

9 months โ†‘ 62.20%

Primo Brands maintains strong momentum with a 9-month winning streak (21.88 โ†’ 35.49), delivering 62.2% gains. With 1.6B revenue generating only 28.7M profit (1.8% margin) in Qtr ending Mar 2025, the market prices in future margin expansion potential.

7 months โ†‘ 5.55%

Rithm Capital builds on success with a 7-month winning streak (23.80 โ†’ 25.12), delivering 5.5% gains. With 493.0M revenue generating only 80.7M profit (16.4% margin) in Qtr ending Mar 2025, the market prices in future margin expansion potential.

9 months โ†“ -40.87%

Biogen experiences extended pressure with a 9-month decline (231.41 โ†’ 136.84), down 40.9%. Weak margins on 2.4B revenue with only 240.5M profit (9.9% margin) in Qtr ending Mar 2025 validate market skepticism. Structural improvements needed before sentiment shifts.

7 months โ†“ -24.10%

Merck & Co encounters challenges with a 7-month decline (118.26 โ†’ 89.76), down 24.1%. However, fundamentals remain robust: 15.5B revenue generating 5.1B profit (32.7% margin) as of Qtr ending Mar 2025 suggests this could be a temporary setback. Value hunters take note.

8 months โ†‘ 80.82%

Paycor HCM shows consistent strength with a 8-month winning streak (12.41 โ†’ 22.44), delivering 80.8% gains. Despite 180.4M in revenue and - 2.0M loss (-1.1% margin) as of Qtr ending Dec 2024, the market sees potential beyond current profitability. This momentum suggests confidence in future execution.

8 months โ†‘ 57.66%

SolarWinds builds on success with a 8-month winning streak (11.69 โ†’ 18.43), delivering 57.7% gains. The financials tell a compelling story: 210.3M revenue generating 72.7M net profit (34.6% margin) demonstrates exceptional profit margins as of Qtr ending Dec 2024.

9 months โ†“ -65.07%

Axcelis experiences extended pressure with a 9-month decline (142.19 โ†’ 49.67), down 65.1%. However, fundamentals remain robust: 192.6M revenue generating 28.6M profit (14.8% margin) as of Qtr ending Mar 2025 suggests this could be a temporary setback. Value hunters take note.

8 months โ†“ -71.53%

Moderna struggles to find footing after a 8-month decline (99.58 โ†’ 28.35), down 71.5%. Financial struggles compound the decline: despite 107.0M revenue, - 971.0M losses persist (-907.5% margin) as of Qtr ending Mar 2025. Until profitability improves, caution remains warranted.

6 months โ†‘ 39.12%

Air Transport shows consistent strength with a 6-month winning streak (16.13 โ†’ 22.44), delivering 39.1% gains. With 516.8M revenue generating only 14.7M profit (2.8% margin) in Qtr ending Dec 2024, the market prices in future margin expansion potential.

5 months โ†‘ 142.75%

Paragon gains traction with a 5-month winning streak (5.38 โ†’ 13.06), delivering 142.8% gains. Despite 71.7M in revenue and - 11.1M loss (-15.5% margin) as of Qtr ending Dec 2024, the market sees potential beyond current profitability. This momentum suggests confidence in future execution.

10 months โ†“ -44.01%

Blue Bird struggles to find footing after a 10-month decline (57.81 โ†’ 32.37), down 44.0%. Revenue of 358.9M provides a foundation, but 26.0M net income (7.3% margin) in Qtr ending Mar 2025 highlights operational challenges that need addressing.

9 months โ†“ -57.04%

Veeco Instruments struggles to find footing after a 9-month decline (46.74 โ†’ 20.08), down 57.0%. Weak margins on 167.3M revenue with only 11.9M profit (7.1% margin) in Qtr ending Mar 2025 validate market skepticism. Structural improvements needed before sentiment shifts.

United States Market Monthly Gainers & Losers: March 2025

Top United States Stock Gainers (March 2025)

Stock Month Open Month Close Monthly Change Avg Daily Volume Month Volume
$474.37 $523.75 10.27% 4.2M 93.1M
$68.42 $73.28 8.63% 5.6M 123.0M
$111.70 $118.93 6.83% 17.5M 385.6M
$159.46 $167.29 5.47% 9.0M 198.7M
$516.22 $532.58 3.65% 4.9M 108.2M
$4.60 $31.88 593.04% 1.8M 39.9M
$26.20 $35.62 38.65% 9.1M 199.6M
$333.99 $383.68 23.37% 103.9K 2.3M
$86.35 $100.64 18.61% 3.5K 77.0K
$73.57 $87.93 18.54% 4.5M 98.5M
$61.39 $114.22 88.54% 1.6M 36.1M
$48.93 $71.45 46.35% 1.7M 38.2M
$4.48 $6.10 41.20% 15.7M 345.1M
$5.58 $7.60 38.69% 83.0M 1.8B
$2.75 $3.71 36.40% 20.8M 458.4M
$3.62 $7.00 95.53% 1.3M 29.0M
$11.30 $18.77 68.79% 2.1M 47.0M
$15.77 $23.35 49.30% 1.4M 31.2M
$3.63 $5.22 43.01% 773.7K 17.0M
$6.61 $9.21 38.08% 12.3M 271.7M

Biggest United States Stock Losers (March 2025)

Stock Month Open Month Close Monthly Change Avg Daily Volume Month Volume
$204.00 $167.43 -16.05% 34.2M 751.9M
$166.95 $139.81 -15.81% 11.8M 259.2M
$936.01 $796.14 -14.37% 2.0M 45.0M
$673.68 $576.36 -13.74% 16.5M 363.4M
$114.07 $98.70 -13.27% 9.5M 209.2M
$165.46 $104.90 -35.16% 9.2M 201.3M
$32.81 $21.11 -35.03% 13.0M 286.0M
$44.97 $29.55 -34.46% 21.4M 471.4M
$270.63 $175.40 -34.41% 3.1M 68.2M
$91.99 $61.57 -32.94% 19.6M 432.1M
$73.17 $37.76 -48.29% 1.6M 36.2M
$16.24 $8.82 -45.12% 1.7M 37.2M
$14.64 $8.29 -40.66% 2.0M 44.3M
$24.77 $15.52 -37.75% 10.3M 226.8M
$34.75 $21.63 -35.22% 12.3M 271.4M
$1.50 $1.50 -86.36% 5 100
$0.70 $0.31 -53.73% 650.8K 14.3M
$14.81 $7.45 -48.90% 16.5M 363.3M
$5.49 $2.86 -44.57% 41.5M 913.1M
$4.51 $2.30 -43.63% 12.5M 274.5M

Most Active United States Stocks During March 2025

Stock Month Open Month Close Monthly Change Avg Daily Volume Monthly Volume
$123.51 $108.38 -13.24% 280.8M 6.2B
$9.71 $10.03 5.03% 136.9M 3.0B
$300.34 $259.16 -11.54% 123.6M 2.7B
$88.55 $84.40 -0.61% 100.3M 2.2B
$25.00 $22.71 -4.30% 100.2M 2.2B
$2.27 $2.42 9.01% 92.4M 2.0B
$5.58 $7.60 38.69% 83.0M 1.8B
$4.49 $3.81 -17.71% 67.0M 1.5B
$42.28 $34.24 -17.41% 63.3M 1.4B
$14.36 $10.55 -26.48% 62.2M 1.4B
$1.61 $1.35 -16.15% 60.8M 1.3B
$1.53 $1.30 -12.75% 59.9M 1.3B
$11.00 $10.24 -4.74% 57.3M 1.3B
$8.54 $7.92 -6.38% 55.8M 1.2B
$26.37 $25.34 -4.12% 55.1M 1.2B
$241.79 $222.13 -8.15% 50.7M 1.1B
$2.26 $2.23 -1.33% 45.9M 1.0B
$27.27 $28.28 3.17% 44.5M 978.8M
$5.49 $2.86 -44.57% 41.5M 913.1M
$4.31 $2.73 -34.84% 32.7M 719.0M

United States Sector Performance During March 2025

Consumer Defensive

11.33%
244 stocks
Top Performers by Market Cap:
Mega Cap: PM +2.22%
Large Cap: CELH +38.65%
Small Cap: YSG +26.25%

Industrials

5.15%
695 stocks
Top Performers by Market Cap:
Mega Cap: GE -3.30%
Large Cap: ESLT +23.37%
Mid Cap: WOR +19.29%
Small Cap: ATRO +20.79%

Basic Materials

1.84%
264 stocks
Top Performers by Market Cap:
Mega Cap: LIN -0.30%
Large Cap: KGC +17.63%
Mid Cap: FSM +41.20%
Small Cap: ARMN +25.41%

Real Estate

-0.16%
270 stocks
Top Performers by Market Cap:
Large Cap: CCI +10.77%
Mid Cap: MRP +15.97%
Small Cap: RDFN +38.08%

Utilities

-2.32%
98 stocks
Top Performers by Market Cap:
Large Cap: ED +8.93%
Small Cap: MSEX +27.87%

Financial Services

-3.04%
1048 stocks
Top Performers by Market Cap:
Mega Cap: BRK.B +3.65%
Large Cap: WRB +12.81%
Small Cap: PRA +49.30%

Energy

-3.63%
216 stocks
Top Performers by Market Cap:
Mega Cap: SHEL +8.63%
Large Cap: EXEEL +18.61%
Mid Cap: VRN +21.47%
Small Cap: LPG +9.72%

Communication Services

-4.55%
260 stocks
Top Performers by Market Cap:
Mega Cap: T +3.17%
Large Cap: EA +11.93%
Mid Cap: BZ +19.81%
Small Cap: GRPN +68.79%

Technology

-9.41%
805 stocks
Top Performers by Market Cap:
Mega Cap: AMD +2.88%
Large Cap: OKTA +16.28%
Small Cap: AEVA +95.53%

Consumer Cyclical

-9.96%
591 stocks
Top Performers by Market Cap:
Mega Cap: MCD +1.31%
Large Cap: AZO +9.15%
Mid Cap: SIG +10.97%
Small Cap: TRS +14.35%

Healthcare

-11.20%
1212 stocks
Top Performers by Market Cap:
Mega Cap: UNH +10.27%
Large Cap: RGC +593.04%
Small Cap: ASTH +22.18%

Data is updated regularly. Monthly performance is calculated based on closing prices.